ISTITUTO EUROPEO DI ONCOLOGIA SRL - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Total Project Funding:100-200
Networking Rank (Reputation):400-500
Partner Constancy:400-500
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:100-200
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 35
As coordinator: 1
As participant: 33
Sole participant: 1
Coordinator / Participant Ratio: 0.03*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 4.142.397 303.155 2
2019 0 13.930.695 488.125 2
2018 150.000 8.564.406 623.193 1 2
2017 0 25.445.853 2.057.166 4
2016 2.500.000 6.000.000 1.712.912 1 1
2015 0 25.593.416 1.475.955 6
2014 0 6.497.804 6.189.800 3
2013 0 4.263.618 453.174 2
2011 0 87.174.464 8.739.769 8
2010 0 18.392.711 433.097 3

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY9
UNIVERSITY OF COPENHAGEN7
INSTITUT CURIE6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS4
HUMANITAS UNIVERSITY4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KING'S COLLEGE LONDON4
UNIVERSITA DEGLI STUDI DI MILANO4
ACADEMISCH ZIEKENHUIS GRONINGEN3
CENTRE DE REGULACIO GENOMICA3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO CENTRE DE REGULACIO GENOMICA3
INSTITUT PASTEUR3
KAROLINSKA INSTITUTE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW3
LUNDS UNIVERSITET3
MASARYKOVA UNIVERZITA3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
STICHTING KATHOLIEKE UNIVERSITEIT3
THE BABRAHAM INSTITUTE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITAET DES SAARLANDES3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF CAMBRIDGE3
UPPSALA UNIVERSITET3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH ZIEKENHUIS LEIDEN2
CELLZOME2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
DIAGENODE2
ECANCERMEDICALSCIENCE2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GOETEBORGS UNIVERSITET2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT CATALA D'ONCOLOGIA2
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE2
INSTITUT GUSTAVE ROUSSY2
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN2
MEDICAL RESEARCH COUNCIL2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
OSLO UNIVERSITETSSYKEHUS HF2
PHILIPS ELECTRONICS NEDERLAND B V2
SYDDANSK UNIVERSITET2
TECHNISCHE UNIVERSITEIT DELFT2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET LEIPZIG2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITE DE GENEVE2
UNIVERSITEIT ANTWERPEN2
UNIVERSITY OF BIRMINGHAM2
UNIWERSYTET WARSZAWSKI2
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE2
VIB2
A PERSIDIS & SIA OE1
AARHUS UNIVERSITETSHOSPITAL1
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ABBVIE1
ABO AKADEMI1
ACIES SAS1
ACTELION PHARMACEUTICALS1
ADVANCED BIODESIGN1
AGENCIA D'INFORMACIO AVALUACIO I QUALITAT EN SALUT1
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA1
AGILENT TECHNOLOGIES OESTERREICH1
AM2M SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA KOMANDYTOWA1
AMGEN LIMITED1
ANNOGEN BV1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ASSEMBLEA DELLE DONNE PER LO SVILUPPO E LA LOTTA ALL'ESCLUSIONE SOCIALE ASDO1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA AB1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BAYER PHARMA1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOBYTE SOLUTIONS1

Constancy:

Total number of partners: 441
Partner loyalty:
Frequent Partner: (> 2 projects): 137
Rare Partner: 304
Frequent / Rare Partner Ratio: 0.45

Project overview:

Start dateProjectacronymrolefundingpartners
2020-07-01Deacetylase inhibitors for autism spectrum disorders: an integrated preclinical validation pipeline in brain organoids and in vivo models DUPDOWNparticipant150.0002
2020-03-01Molecular basis of human enhanceropathies ENHPATHYparticipant3.992.39717
2019-04-01AuTonomous intraLuminAl Surgery ATLASparticipant3.944.50921
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-09-01Chromatin architecture and Design ChromDesignparticipant3.408.20717
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2018-01-01Immuno-targeting of human AML quiescent cells by a novel phage display approach. ITHACAcoordinator150.0001
2017-11-01Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity DissectPcGparticipant2.000.0002
2017-11-01Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back BOUNCEparticipant4.999.4109
2017-01-01SMart weArable Robotic Teleoperated Surgery SMARTsurgparticipant3.990.20611
2017-01-01A Systems medicine approach to chronic inflammatory disease SYSCIDparticipant14.456.23616
2016-11-01The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators MEDICIcoordinator2.500.0002
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.52510
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-09-01Female cancer prediction using cervical omics to individualise screening and prevention FORECEEparticipant7.994.74614
2015-05-01Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds EDC-MixRiskparticipant6.223.33012
2015-02-01iManageCancer - Empowering patients and strengthening self-management in cancer diseases iManageCancerparticipant4.856.17410
2015-01-01European Consortium for Communicating Stem Cell Research EuroStemCellparticipant600.00031
2014-09-01Modeling Disease through Cell Reprogramming: a Translational Approach to the Pathogenesis of Syndromes Caused by Symmetrical Gene Dosage Imbalances DISEASEAVATARSparticipant1.997.8042
2014-07-01Inside mechanisms sustaining cancer stem cells INMECparticipant2.500.0001
2014-07-01Immune mechanisms that control the homeostasis of the gut and that are deregulated in intestinal pathologies cancer HOMEOGUTparticipant2.000.0002
2013-11-01Universal Flu Vaccine UNIVACFLUparticipant4.116.7018
2013-07-017kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis 7TREIMHOparticipant146.9172
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-07-01"Connecting the activities of c-Myc in genome regulation, cellular growth control and oncogenesis" MYCNEXTparticipant2.494.0001
2011-06-01The genomic blueprint of macrophages: dissecting players and mechanisms through an integrative approach NORMparticipant2.436.2001
2011-02-01From data sharing and integration via VPH models to personalised medicine p-medicineparticipant13.329.89819
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-12-01Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences Euro-BioImagingparticipant5.198.24442
2010-07-01AnThocyanin and polyphenol bioactives for Health Enhancement through Nutritional Advancement ATHENAparticipant2.996.22613
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114

Alias institution names:

  • ISTITUTO EUROPEO DI ONCOLOGIA